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1122Objective: There is no optimal substitute for right ventricular outflow tract (RVOT) reconstruction in
congenital heart defects. Expanded polytetrafluoroethylene (ePTFE) valved conduits and patches may be
a good alternative to homografts and bovine jugular veins. We have developed a fan-shaped ePTFE valve
and an ePTFE valved conduit and patch with bulging sinuses with the aim of enhancing the long-term valve
function.
Method: Bulging sinuses were constructed on ePTFE conduits and patches as described previously (J Thorac
Cardiovasc Surg. 2007;134:327-32). Between February 2001 and January 2011, 794 patients (aged 14 days to
56.8 years old; median, 2.0 years old) had ePTFE valves implanted for RVOT reconstruction at 52 Japanese
institutes. Conduits with a fan-shaped ePTFE valve were implanted in 325 patients and a patch with
a fan-shaped ePTFE valve was implanted in 469 patients. Valve function was assessed by a series of echo-
cardiograms postoperatively.
Results: The mean follow-up was 3.6 years (1.1 months to 10.0 years). Freedom from reoperation at 10 years
was 95.4% in patients with conduits and 92.3% in those with patches. Pulmonary insufficiency was mild or non-
existent in 95.0% of patients with conduits and 79.6% of patients with patches. The pressure gradient between
the right ventricle and the pulmonary artery was 14.0  13.2 mm Hg in patients with conduits and 11.6  11.6
mm Hg in patients with patches.
Conclusions: Fan-shaped ePTFE valved conduits and patches with bulging sinuses have a high freedom from
reoperation and prevent pulmonary insufficiency. They represent a promising material for RVOT reconstruction.
(J Thorac Cardiovasc Surg 2011;142:1122-9)Video clip is available online.
Right ventricular outflow tract (RVOT) reconstruction is
one of the most distinctive surgical procedures in the treat-
ment of congenital heart disease. Although many materials
can be used in RVOT reconstruction, somematerials may be
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The Journal of Thoracic and Cardiovascular Surprostheses such as bovine jugular vein are standard mate-
rials for RVOT reconstruction. Homograft or bovine jugular
vein offers superior pliability and good handling character-
istics. In addition, bovine jugular vein can be obtained in
a wide range of sizes. However, the long-term availability
and durability of these materials is unsatisfactory, espe-
cially in younger children.
Because of legal problems, as well as particular regional
reasons, these materials are unavailable in our country.
Therefore, handmade expanded polytetrafluoroethylene
(ePTFE) valves have been most commonly used.1-4
Midterm and long-term valvular function of the ePTFE
valve has not been shown to be inferior to that of homograft
or bovine jugular vein. Indeed, ePTFE has good biocompat-
ibility, and its microporous structure impedes cellular pen-
etration and subsequent calcification, which is a common
cause of valvular dysfunction. Excised ePTFE valves have
been found to be covered by thin fibrous tissue without ev-
idence of calcification, and immunohistochemical analysis
has revealed focal regions of endothelialization.2,5-7
We1,6,8 previously developed a fan-shaped valve made
from a 0.1-mm thick ePTFE membrane (Preclude Pericar-
dial Membrane; W.L. Gore & Associates, Inc, Flagstaff,gery c November 2011
Abbreviations and Acronyms
ePTFE ¼ expanded polytetrafluoroethylene
RVOT ¼ right ventricular outflow tract
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margin was originally designed to prevent pulmonary regur-
gitation.8 Moreover, bulging sinuses were attached to
ePTFE valved conduits and patches to enhance long-term
valve function.9 At the initial construction of the bulging si-
nuses, the ePTFE graft needs to be formally opened because
the bulging sinuses are formed from flat stainless molds.9
After the bulging sinus has been formed and the fan-
shaped valve anastomosed, the graft is rolled up and sutured
to form a conduit.9 Starting in 2010, it was no longer neces-
sary to cut open the ePTFE owing to improved fabrication
techniques. The bulging sinuses are formed on the graft as
depicted in Figure 1.
The fan-shaped valves are created according to a specific
protocol. After formation of the bulging sinuses, the graft is
turned inside out and the fan-shaped valves are sutured
around the edge of the bulging sinuses (Video 1). There
are 3 surgeons who complete the grafts from start to finish.
Two of the surgeons created sinuses on the graft following
a specific protocol, and the author (T.M.) personally sutured
all the cusps on all of the conduits and the patches that were
implanted in this study. The conduits and the patches were
created in advance in the operating room, and all of the fin-
ished valves were sterilized at Kyoto Prefectural University
of Medicine and delivered to the 52 Japanese institutes as
needed.
This study was approval by the Institutional Review
Board at Kyoto Prefectural University of Medicine.FIGURE 1. A new version of ePTFE valved conduit with bulging sinus. A, Vi
valves are not anastomosed yet. B, View from above. Fan-shaped valves that a
The Journal of Thoracic and CarDATA COLLECTION AND STATISTICAL
ANALYSIS
This study was a multicenter study with each patient
followed up at respective institutes. Follow-up was 100%
complete with no patients lost to follow-up. Preoperative
and postoperative data were collected retrospectively from
the patients’ medical records from each institute. The conduit
diameters at the time of insertion were converted into
a Z-value by regression analysis based on previously pub-
lished nomograms10,11 and a predicted pulmonary valve size
was determined using a historically validated nomogram12
indexed to the body surface area.
So that the presence of pulmonary regurgitation could be
assessed and the mean blood pressure gradients across the
valve determined, all patients periodically underwent trans-
thoracic, 2-dimensional, color flow Doppler echocardiogra-
phy in the M-mode during follow-up at each institute. The
degree of pulmonary regurgitation was based on a 5-grade
semiquantitative scale (0, none; 1, trivial; 2, mild; 3, mod-
erate; or 4, severe) according to features of the jet flow as
measured by pulsed Doppler echocardiography. All data
are expressed as mean  standard deviation. The Kaplan-
Meier product limit method was used to analyze the free-
dom from reoperation.PATIENTS AND METHODS
Between February 2001 and January 2011, a total of 794 patients under-
went RVOT reconstruction using fan-shaped ePTFE valves and ePTFE
valved conduits and patches with bulging sinuses in 52 Japanese institutes.
A total of 325 patients required valved conduits (group C) and 469 patients
required valved patches (group P). Conduits were chosen for patients with
pulmonary atresia, truncus arteriosus, or Ross candidates who had discon-
tinuity between the right ventricle and the pulmonary artery. Conduits were
also used in adolescents and adults who needed pulmonary valve replace-
ments. On the other hand, we used patches in cases of tetralogy of Fallot or
other congenital cardiac disorders with a narrow pulmonary annulus.ew from outside. An ePTFE conduit only with bulging sinuses; fan-shaped
re anastomosed at the edge of the bulging sinuses and tightly sealed.
diovascular Surgery c Volume 142, Number 5 1123
TABLE 1. Anatomic diagnoses
Procedure Diagnosis Conduit Patch
Construction of RV-PA
continuity
269 456
TOF/DORV/VSD + pulm atresia 150 74
TOF/DORV + PS 36 315
TOF + APV 12 15
Pulm atresia + IVS 4 9
TGA + PS 9 9
cTGA + pulm atresia 4 1
cTGA + PS 8 1
Truncus arteriosus 21 7
Others 25 25
Ross procedure 56 13
AS 19 6
ASR 23 4
AR 14 3
Total 325 469
TOF, Tetralogy of Fallot;DORV, double-outlet right ventricle; VSD, ventricular septal
defect; pulm atresia, pulmonary atresia; PS, pulmonary stenosis; APV, aortopulmo-
nary valve; IVS, intact ventricular septum; TGA, transposition of the great arteries;
cTGA, corrected transposition of the great arteries; RV, right ventricle; PA, pulmonary
artery; AS, aortic stenosis; ASR, aortic stenosis and regurgitation; AR, aortic
regurgitation.
FIGURE 2. A, Patients’ body weight and diameter of the conduits. B,
Patients’ body weight and Z-value of the conduits. BW, Body weight.
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posterior wall of the RVOT in neonates and infants who had discontinuity
between the right ventricle and the pulmonary artery. The anterior wall of
the RVOT was covered with the ePTFE valved patches. The anatomic
diagnoses are listed in Table 1.
We attempted to position the valve at the same location as the native pul-
monary annulus. When the valve had to be located at the distal position of
the native pulmonary annulus (Video 2), the valve was positioned to avoid
compression by the sternum. We performed RVOT reconstruction only us-
ing the ePTFE conduit and did not create a hood over the RVOT (Video 2).
The median age at the time of operation was 4.8 years old (15 days to
56.8 years old) in group C and 1.4 years (14 days to 45.6 years old) in group
P. There were 81 patients (24.9%) in group C and 319 children (68.0%) in
group P younger than 2 years of age. Median body weight at the time of
surgery was 13.5 kg (2.1-87.0 kg) in group C and 9.0 kg (1.5-84.6 kg) in
group P. One hundred nine (33.5%) patients in group C and 31 (6.6%)
in group P had previous RVOT reconstruction with prosthetic valves.
The conduits had tricuspid valves in 317 patients, bicuspid valves in 7 pa-
tients, and a monocuspid valve in 1 patient. The diameters of the conduits
were 8 mm (bicuspid valve) in 1 patient, 10 mm in 3 patients (tricuspid
valve in 2 and bicuspid in 1), 12 mm in 10 patients (tricuspid valve in 5 pa-
tients, bicuspid in 4, and monocuspid in 1), 14 mm in 6 patients (tricuspid
valve in 5 and bicuspid in 1), 16mm in 99 patients, 18mm in 75 patients, 20
mm in 9 patients, 22 mm in 86 patients, and 24mm in 34 patients. All of the
conduits in which the diameter was over 16 mm had tricuspid valves.
Conduit size was determined by estimating 140% of the normal size of
the pulmonary annulus as calculated using the formula of Rowlatt.12
Figure 2, A, shows the patients’ body weight and the diameters of the con-
duits used, and Figure 2, B, shows the body weight and Z-value. The con-
duit’s Z-value at implantation was 1.7 1.4 (ranging from2.5 to 4.6) and
its size as a percentage of the normal pulmonary annulus was 138% 17%
(93%-217%). Conduit characteristics are listed in Table 2. The Z-value at
implantation was 2.4 2.1 in patients weighing less than 5 kg (10 patients),
2.4  0.8 for patients between 5 and 10 kg (88 patients), 1.9  0.9 for pa-
tients between 10 and 20 kg (98 patients), and 0.0 1.0 for patients weigh-
ing more than 20 kg (128 patients). Furthermore, the Z-value was 2.4 1.01124 The Journal of Thoracic and Cardiovascular Surin patients younger than 2 years of age (81 patients), 2.1  1.0 for patients
between 2 and 5 years (86 patients), 1.5 0.9 for patients between 5 and 10
years (50 patients), 0.6  1.0 for patients between 10 and 15 years (47 pa-
tients), and0.3  0.7 for patients older than 15 years (61 patients).
We previously used bicuspid or monocuspid valves for patients weigh-
ing less than 12 kg who needed conduits with diameters of 14 mm or
smaller because of the difficulty in making small sinuses and small tricus-
pid valves that would be accommodated. However, starting in 2010, we be-
gan making tricuspid valved conduits with diameters of 14, 12, and 10 mm
with new fabrication techniques.
The patches had a monocuspid valve in 431 patients, bicuspid valve in
35 patients, and tricuspid valves in 3 patients. Tricuspid and bicuspid
patches were used in the early series, but currently, monocuspid patches
are used in almost every case. The diameter of the sinus of the patch was
decided according to the size of the autologous tissue used as the posterior
wall in RVOT reconstruction. That is, after RVOT reconstruction, the pul-
monary annulus was 130% of normal size as calculated by the formula of
Rowlatt.12
Patients were followed up for 3.6  2.2 years (range, 1.1 month to 10.0
years). One hundred twenty-three (37.8%) patients in group C and 297
(63.3%) in group P had postoperative cardiac catheterization. From the
297 patients in group C and 397 patients in group P, confidence interval
data of the most recent echocardiograms and cardiac catheterizations
was obtained. No patients needed routine anticoagulation or antiplatelet
therapy.RESULTS
Echocardiography, cardiac catheterization, or magnetic
resonance angiography revealed that the ePTFE leaflets
were functioning well in all but 3 patients. No leaflet wasgery c November 2011
TABLE 2. Conduit characteristics (n ¼ 325)
Conduit size (mm) No. Age Body weight (kg) Z-value % of normal size
8 1 2.2 m 2.1 1.0 125
10 3 6.2  7.5 m 6.0  1.8 0.1  0.8 107  11
12 10 4.5  9.7 m 5.3  2.3 1.5  1.6 130  17
14 6 1.0  1.0 y 7.5  1.5 1.5  0.7 135  7
16 99 2.1  2.5 y 9.5  5.7 2.1  1.0 139  18
18 77 3.3  9.7 y 12.0  9.7 2.3  1.5 146  19
20 9 7.2  3.7 y 19.3  10.2 1.5  1.3 141  14
22 86 13.0  7.8 y 36.0  15.2 0.5  1.3 134  14
24 34 17.6  9.2 y 56.0  12.1 0.1  0.6 135  5
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Dcompletely fixed in the open position, and none had evi-
dence of calcification or peel formation.
Conduits
There were 3 early and 5 late deaths, but these were not
related to the valves. Two patients required explantation
of the conduits. These 2 patients with 12-mm conduits re-
quired reoperation at a duration of 5.7 and 5.8 years be-
cause of pulmonary stenosis secondary to their growth.
Both patients received 18-mm conduits. The degree of pul-
monary regurgitation was none in 68 (22.9%) patients, triv-
ial in 134 (45.2%), mild in 80 (26.9%), moderate in 14
(4.7%), and severe in only 1 (0.3%) patient (Figure 3).
The mean peak pressure gradients between the pulmonary
artery and the right ventricle were 14.0  13.2 mm Hg
(range, 0-72.9 mm Hg). The gradients were more than
50 mm Hg in 8 patients, but they remained asymptomatic.
Freedom from reoperation was 100% at 5 years and
95.4% at 10 years (Figure 4). Breaking down freedom
from reoperation by conduit diameter, 8- to 16-mm diame-
ters were 100% free at 5 years and 72.9% free at 6 years,
whereas 18- to 24-mm diameters were 100% free at 10
years (Figure 4).
Two female patients who underwent the Ross procedure
using 24-mm conduits were delivered of babies 32 and 53
months after the operation.
Patches
There were 6 early and 6 late deaths in patients receiving
patches, but no deaths were related to the valves. Six
patients required explantation of the patches at a duration
of 3.3  2.4 years (2.2-8.4 years). Four patients required
reRVOT reconstruction because of RVOT stenosis and 2 pa-
tients needed replacement for valvular insufficiency. Four
patients underwent reRVOT reconstruction using valved
conduits. The degree of pulmonary regurgitation was
none in 34 (8.6%) patients, trivial in 89 (22.4%), mild in
193 (48.6%), moderate in 76 (19.1%), and severe in 5
(1.3%) patients (Figure 3). The mean peak pressure gradi-
ents between the pulmonary artery and the right ventricle
were 11.6  11.6 mm Hg (range, 0-67.9 mm Hg). TheThe Journal of Thoracic and Cargradients were more than 50 mm Hg in 4 patients, but
they remained asymptomatic. Freedom from reoperation
was 98.6% at 5 years and 92.3% at 10 years (Figure 4).
DISCUSSION
A range of materials including autologous pericardium,
porcine pulmonary valves, Dacron grafts, mechanical valves,
bovine jugular veins, and homografts have been used for
RVOT reconstruction. Porcine pulmonary valves have been
fraught with early degeneration and in some cases have
caused pulmonary stenosis.13 Complications from Dacron
grafts include obstruction owing to a thick neointimal peel
that requires explantation.14 Mechanical valves, albeit dura-
ble, require anticoagulation.15 Early degeneration and calcifi-
cation are inevitable complications in commonly used
homografts and bovine jugular veins.13 Unfortunately, their
long-term availability and durability are unsatisfactory.13-15
Recently, late complications of RVOT reconstruction
have been reported and include arrhythmias, heart failure,
sudden death, and the need for repeat RVOT reconstruction
as a result of right ventricular dysfunction, stenosis of
the RVOT, and, most important, the deleterious effects of
pulmonary regurgitation.16-18 A better prosthetic valved
conduit or patch that is readily available and will be
reliable for a long time is needed. Even homografts and
bovine jugular veins used as valved conduits have
complications owing to pulmonary insufficiency and have
higher reoperation rates as compared with our ePTFE
valves.13,19,20
We previously mentioned the good biocompatibility of
ePTFE, as well as its microporous structure, which impedes
cellular penetration. To enhance the function of the ePTFE
valve, we developed a fan-shaped cusp, which has a long
margin and curve to make a large coaptation zone. This
more closely approximates the configuration of the natural
semilunar valve.8 The fan-shaped ePTFE valve has demon-
strated satisfactory results1,7; however, some fan-shaped
valves were prone to sticking in the open position.6 In
ePTFE valves that were stuck in the open position, the cause
was not calcification or sclerosis but an inadequate closure
effect.6 Therefore, we developed a bulging sinus on thediovascular Surgery c Volume 142, Number 5 1125
FIGURE 3. Pulmonary regurgitation.
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nus of Valsalva.9 Ohta and coworkers21 reported the effect
of the sinus of Valsalva on the closing motion of bileaflet
prosthetic heart valves. The vortex flow in the sinus of
Valsalva pushes the leaflet closed, and the valve starts the
closing motion earlier than the prosthetic valve as the for-
ward flow decelerates. This closing mechanism is thought
to decrease backflow during valve closure, like a naturalFIGURE 4. Kaplan-Meier fr
1126 The Journal of Thoracic and Cardiovascular Surseminular valve. Bulging sinuses demonstrated the same
closing mechanisms in engineering experiments using a pe-
diatric right heart circulation model.22 A high-speed video
camerawas used to visualize leaflet motion and streamlines.
Existence of bulging sinuses demonstrated a lower pressure
gradient through the valves, a larger effective opening area,
a faster response of valve movement, a lower energy loss at
the valve, and less regurgitant flow at the valve. In addition,eedom from reoperation.
gery c November 2011
FIGURE 5. Echocardiographic evaluation of the vortex flow along the bulging sinuses. A,White arrows indicate velocity vector at bulging sinuses of the
ePTFE conduit. B,White arrows indicate counterclockwise vortex flow at bulging sinuses of the ePTFE conduit. ePTFE, Expanded polytetrafluoroethylene.
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dient and less regurgitant flow. The combination of a bulging
sinus and a fan-shaped valve experimentally demonstrated
the best valve function to prevent pulmonary regurgitation
as well as stenosis.22 Vortex flow along the bulging sinuses
of the ePTFE conduit was certainly confirmed during the
late ejection period by echo-dynamography (Aloka, Tokyo,
Japan) (Figure 5).
In addition, surgical techniques are important in prevent-
ing pulmonary insufficiency. Turrentine and colleagues7
adopted a transannular ePTFE monocuspid patch in
RVOT reconstruction. They reported that a bullet-shaped
piece of 0.1-mm ePTFE is fashioned by placing the material
in the ventricular portion of the opening and allowing it to
lay flush along the ventricular walls and conal septum,
thereby maximizing surface area coaptation. We think this
design of the valve is too big to close naturally. Most of
the valve is covered inside the right ventricle; in other
words, the valve is so long that a large amount of energy
is necessary to close it, which predisposes the valve to be-
coming fixed in the open position, as well as increasing
its risk of pannus formation. In this regard, the design of
our fan-shaped valve is not long enough to move the hole
of the valve. Furthermore, the vortex flow along the bulging
sinuses can lead the valve to close all the time.
In cases of tricuspid conduit replacement of the RVOT, 1
of the cusps is placed in the greater curvature of the RVOT
and the other 2 cusps are placed in the lesser curvature in the
same location as the natural semilunar valves (Video 2).
This allows for the most hydrodynamically advantageous
placement. That is, this positioning is considered appropri-
ate because of the fast flow velocity in the greater curvature
of the RVOT. The number of patients with bicuspid valved
conduits was few, so we cannot draw a comparison between
bicuspid valved conduits and tricuspid valved conduits.
However, in our series, no leaflet was completely fixed in
the open position and the design appeared to prevent pulmo-
nary insufficiency. Therefore, tricuspid valves might be
ideal for achieving optimal long-term valve function.The Journal of Thoracic and CarIn group P, 81 (20.4%) patients had at least a moderate
amount of regurgitation. This degree of regurgitation was
higher than that of group C (5.0%). This might be due to
the quality of the native valve, which makes up the posterior
wall of the RVOT. In the case of severe pulmonary stenosis
like a fish-mouth pulmonary valve, we prefer a conduit
repair for RVOT reconstruction because the native valves
are not expected to have sufficient valve function.
It is a controversial problem to choose an optimal size of
the conduit.23,24 Invariably, patients who had a smaller
conduit had a higher likelihood of needing a reoperation.
An optimal conduit size might prolong the interval to the
subsequent operations. Interestingly, it has been reported
that oversized allografts do not improve durability.23,24 In
our series, conduit size was determined to be about 140%
of the normal size of the pulmonary annulus as calculated
by the formula of Rowlatt.12 Under this strategy, the free-
dom from reoperation was low, even in the group with small
conduit diameters (8-16 mm). Furthermore, younger age is
a risk factor for conduit dysfunction. We propose that a Z-
value of 2.4 can be a criterion for determining conduit
size. It is striking that the patients who received conduit
sizes over 18 mm did not need reoperation.
Although only 2 patients who underwent RVOT recon-
struction using 12-mm conduits needed reoperation, the
freedom from reoperation was 72.9% at 6 years in the small
conduit group (conduit diameter, 8-16 mm). This was be-
cause the small conduits were developed later and so the
mean follow-up time of patients with small conduits was
2.9 1.8 years (the longest follow-up was 6.8 years), which
is a relatively short time period. However, a 72.9% rate of
freedom from reoperation at 6 years is an adequate result.
With the growth of the adult population with congenital
heart disease, pregnancy becomes an issue because of vol-
ume overload of the right ventricle in female patients. In
our series, 2 female patients who underwent RVOT recon-
struction using ePTFE valved conduits were delivered of
babies. One of them had a vaginal delivery. The conduit
was able to protect the right ventricle so that she coulddiovascular Surgery c Volume 142, Number 5 1127
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fore, these valves might be suitable for female patients who
want to have children.
We have to construct these valves ourselves, and ePTFE
is slightly stiffer for suturing than homografts and bovine
jugular veins. However, ePTFE valves can be made to any
desired size, are easy to construct, have good biocompatibil-
ity, and are relatively inexpensive. Although further
follow-up is necessary, especially for the small conduits,
the combined effectiveness of the ePTFE conduits and
patches with bulging sinuses and the fan-shaped ePTFE
valves have a low freedom from reoperation and prevent
pulmonary insufficiency, making it a promising material
for RVOT reconstruction.
CONCLUSION
ePTFE has good biocompatibility, making it an ideal ma-
terial for surgical prostheses. A newly developed fan-shaped
valve with bulging sinuses on ePTFE conduits and patches
has beneficial effects on the long-term valve function in
RVOT reconstruction. These valves can accomplish excel-
lent midterm outcomes even with smaller-sized conduits
and can be a promising material for RVOT reconstruction.
We are grateful to all the institutions that were included in this
study for providing data for this manuscript.
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Dr Andres J. Schlichter (Buenos Aires, Argentina). I thank the
authors for sending me the manuscript in advance. I sincerely con-
gratulate them for this nice, neatly presented paper, which I really
enjoyed. It addresses an old and recurrent problem with conduits.
The patients usually outgrow them or their condition tends to de-
teriorate in the years after the so-called correction of the malfor-
mations. Really, no procedure using a conduit to connect the
right ventricle to a pulmonary artery is a correction of the disease.
It is a palliation.
Our group has addressed this problem since 1983 with autolo-
gous pericardial valved conduits. These have been shown to
increase in diameter with the growth of the patient, but unfortu-
nately, their valvular function has a short life. The ePTFE conduit
here shown constructed with bulging sinuses follows the idea
outlined by Leonardo da Vinci more than 500 years ago for the
mechanism of closure of the sigmoid valves.
Apparently, the conduit here presented has a longer functioning
valvular durability, and no degeneration has yet been demon-
strated, as opposed to homografts and other xenografts. The fan-
shaped valves with vortex-like flow are a great improvement.
It is really surprising that even the smaller-sized conduits had
a relatively long follow-up time, some 5 years, before needing ex-
plantation. This is more notable in the smallest sizes, 8 and 10 mm,
which we all would presume to become obstructive very soon after
implantation. The indication for replacement for the conduit wasgery c November 2011
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Dmostly for obstruction, with pressure gradients of 50 mm Hg.
Maybe you should have divided the conduits into 3 groups: one
from 8 to 14 mm (20 patients), a second, 16 mm to 18 mm, and
a third, 18 mm and larger. Had you done so, do you think that
the smaller conduits would have a significantly shorter life than
the 6-year freedom from reoperation you had for your first group?
DrMiyazaki. I appreciate your comment and I would like to an-
swer your question. As you pointed out, problems with RVOT re-
construction are conduit stenosis, lack of growth potential, and,
most important, the pulmonary regurgitation that will be the late
cause of right ventricular dysfunction. An autologous pericardial
valved conduit is an ideal material from the standpoint of growth
potential. However, we have used autologous pericardial valved
conduits that did not maintain the valve function for a long time,
and we could not identify whether the autologous pericardium
had a growth potential or not. In addition, unfortunately, autologous
pericardial valves have been fraught with early degeneration and in
some cases have caused pulmonary stenosis. Furthermore, because
of legal problems, as well as particular regional reasons, homograft
and bovine jugular veins are unavailable in our country. Therefore,
we have developed handmade ePTFE valves.
To answer your first question: When dividing patients into 3
groups, the freedom from reoperation at 6 years in the smaller con-
duit (8-14 mm) is 60%, in the medium-sized conduit (16-18 mm)
100%, and larger conduit (20-24 mm) 100%. However, small in-
fants cannot escape from the smaller conduit implantation, and I
think that this result is significantly better than the result of
small-sized homografts and is equivalent to or better than the result
with the Contegra valved conduit (Medtronic, Inc, Minneapolis,
Minn). Moreover, the reason for the reoperation was patient
somatic growth, not the dysfunction of the valved conduit.
We decided the indication for conduit replacement was a pres-
sure gradient of 50 mm Hg. However, we try to intervene earlier if
we think that the patient can receive a big enough conduit to pre-
vent right ventricular dysfunction, even if the pressure gradient is
less than 50 mm Hg.
Dr Schlichter. That is a very nice answer.
Regarding the patches, you state that on some occasions you re-
construct the posterior wall with autologous pericardium and then
complete the outflow tract by placing the ePTFE valve anteriorly.
My second question is in 2 parts. First, do you suture ePTFE
valves on the posterior right ventricular–pulmonary artery conti-
nuity, too? Second, if you do not suture a valve on the posterior as-
pect of the outflow and you use only a monocusp on the patch, do
you suspect that this may be the cause for a higher percent of pul-
monary incompetence in the patients in the patch group as com-
pared with the conduit group? The anterior cusps may coapt
with the posterior wall at the time of surgery, but when the poste-
rior aspect dilates or grows, it may be foreseen that the ePTFE
valves will not coapt any more.
DrMiyazaki. To answer the first question, yes, we sutured a bi-
cuspid fan-shaped ePTFE valve to the posterior pericardial right
ventricle–pulmonary artery continuity. However, we do not have
data on how to reconstruct the posterior right ventricle–pulmonary
artery continuity at the other institutions involved in this study.The Journal of Thoracic and CarTo answer the second question, when we reconstruct the RVOT
using a monocuspid patch and valveless autologous pericardium,
I suspect this might be the cause for the higher percentage of
pulmonary incompetence.
We think that the growth potential is the other important factor
for small children, and we are using the autologous material for the
posterior wall reconstruction. The majority of patients who need
RVOT reconstruction with autologous pericardium in the posterior
wall and the monocuspid patch in the anterior wall had more com-
plex anatomy such as truncus arteriosus. However, as you indi-
cated, the growing or dilating posterior wall may end up with
noncoapting leaflets that were initially working well, so we have
developed a fan-shaped valve that has a long circular margin
that possesses a large coaptation zone.
Furthermore, we used patches in cases of tetralogy of Fallot or
other congenital cardiac disorders with a narrow pulmonary annu-
lus. In our series, the patients with patches had a greater chance to
have a moderate amount of regurgitation in the long-term than the
patients with conduits. This might be due to the quality of the
native valve, which makes up the posterior wall of the RVOT.
The native valves are very likely to degenerate and cause pulmo-
nary stenosis. When the ePTFE valve leaflets are sutured on the
autologous posterior wall, they are not expected to provide long-
lasting good valve function because of the lack of sinuses.
In addition, in the case of severe pulmonary stenosis like a fish-
mouth pulmonary valve, we prefer a conduit for RVOT reconstruc-
tion, because the native valves are not expected to have sufficient
valve function.
Dr Schlichter.My last question is this: Are you expecting these
ePTFE 0.1-mm membrane valves to have a very long functioning
life or are you suspecting that these will deteriorate with time, too?
I think the incorporation of a longer-lasting valvular function with
the ePTFE fan-shaped valves with bulging sinuses and vortex-like
flow are really an important improvement. Unfortunately, although
an excellent material, PTFE still does not grow, so that the small-
sized conduits will still have to be replaced at least once.
I want to commend your group for the important work done in
this field.
Dr Miyazaki. Indeed, we have used fan-shaped ePTFE valves
without bulging sinuses for over 20 years, and most patients still
have demonstrated a good motion of the leaflet valve. We expect
the 0.1-mm ePTFE membrane valves to have a long valve function
thanks to the bulging sinuses.
Furthermore, Japanese are relatively small built, so we think an
18-mm conduit for female and a 22-mm conduit for male subjects
could stand long use. Although further follow-up will be necessary,
there is a high possibility that reoperation owing to the patient’s
growth and body weight gain is avoidable in both conduit sizes.
DrThoralf Sundt (Boston,Mass). I have a quick question about
biocompatibility.Youmentioned the potential for tissue ingrowth. I
am surprised that tissue ingrowth does not make the valves stiff.
What is the character of the tissue ingrowth to the ePTFE?
Dr Miyazaki. We have no evidence of pannus formation and
calcification that make the valves stiff. I think the reason is that
the valves keep in motion thanks to the bulging sinuses.diovascular Surgery c Volume 142, Number 5 1129
